Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - Zoetis ( NYSE:ZTS )
As the animal health industry navigates a rapidly evolving landscape, companies are increasingly challenged to maintain their competitive edge through innovation and strategic adaptation.
A Look Into Zoetis Inc's Price Over Earnings - Zoetis ( NYSE:ZTS )
In the current market session, Zoetis Inc. ( NYSE:ZTS ) price is at $117.53, after a 0.38% spike. However, over the past month, the stock fell by 20.42%, and in the past year, by 34.17%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is ...
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like PAHC, ATRO, COMM and HRTG are seeing price strength and have a high chance of carrying the momentum forward.
Should You Invest in the VanEck Agribusiness ETF ( MOO ) ?
Sector ETF report for MOO ...
2 Outstanding Dividend Stocks That Are Too Cheap to Ignore
These cheap dividend stocks would make great cornerstone pieces to any portfolio -- especially for investors looking for a deal in today's somewhat expensive market.
CPRX vs. ZTS: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical ( CPRX Quick QuoteCPRX - ) and Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
2 Dividend Stocks to Double Up on Right Now
These healthcare heavyweights have tumbled, causing abnormally high dividend yields.
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
These stocks aren't popular right now, but their strong underlying businesses make them hot deals to pounce on.
Zoetis Stock Outlook Clouded By Rising Competitive Pressures - Zoetis ( NYSE:ZTS )
Animal health firm Zoetis Inc. ( NYSE:ZTS ) on Tuesday reported a third-quarter 2025 adjusted earnings per share of $1.70. The company beat the consensus of $1.62. Adjusted net income was $754 million. That's an increase of 5% on a reported basis, and a rise of 9% on an organic operational ...
ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Zoetis tops Q3 earnings forecasts but misses on revenues and trims 2025 sales outlook, sending shares lower on weak U.S. results.
Zoetis ( ZTS ) Surpasses Q3 Earnings Estimates
Zoetis (ZTS) delivered earnings and revenue surprises of +4.94% and -0.35%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
2 Magnificent Dividend Stocks to Buy and Hold Forever
Some might call them boring businesses, but they have tremendous dividend growth track records.
Seeking Clues to Zoetis ( ZTS ) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect
ZTS is poised for another earnings beat as rising demand for companion animal products like Simparica Trio and Apoquel drives expected Q3 revenue growth.
Earnings Preview: Catalyst Pharmaceutical ( CPRX ) Q3 Earnings Expected to Decline
Catalyst (CPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis ( ZTS ) Reports Next Week: Wall Street Expects Earnings Growth
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis ( ZTS ) Ascends But Remains Behind Market: Some Facts to Note
Zoetis (ZTS) concluded the recent trading session at $147.53, signifying a +1.09% move from its prior day's close.
GRFS vs. ZTS: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols ( GRFS Quick QuoteGRFS - ) or Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like M, PAHC, WDC and ATRO are seeing price strength and have a high chance of carrying the momentum forward.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zoetis Stock: Outlook Remains Muted - Zoetis ( NYSE:ZTS )
Zoetis Inc. ( NYSE:ZTS ) is currently in its final 18th phase of the Adhishthana cycle on the weekly charts. Having formed a poor triad structure, the stock's outlook doesn't look encouraging. With UBS recently lowering its price targets, it adds further weight to the view that Zoetis could stay ...
Xeris Biopharma ( XERS ) Surges 14.2%: Is This an Indication of Further Gains?
Xeris Biopharma (XERS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Why Zoetis ( ZTS ) is Poised to Beat Earnings Estimates Again
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain
ZTS secures CVMP's positive opinion recommending the approval of Lenivia, a long-acting OA pain therapy for dogs, with the final decision expected in late 2025.
2 Magnificent Dividend Stocks to Buy Now and Hold Forever
Both have increased their payouts at a terrific pace over the past decade.
My 2 Favorite Stocks to Buy Right Now
These two stocks will be at the top of my shortlist of stocks to add to in October.
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Zoetis ( ZTS ) Surpasses Market Returns: Some Facts Worth Knowing
Zoetis (ZTS) concluded the recent trading session at $143.5, signifying a +1.68% move from its prior day's close.
Why Is Phibro ( PAHC ) Down 1.1% Since Last Earnings Report?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It?
PAHC rallies 82% YTD with booming vaccines, MFAs and global expansion fueling investor confidence.
How Do Investors Really Feel About Zoetis? - Zoetis ( NYSE:ZTS )
Zoetis's ZTS short interest as a percent of float has risen 17.45% since its last report. According to exchange reported data, there are now 7.76 million shares sold short, which is 1.75% of all regular shares that are available for trading.
Zoetis ( ZTS ) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Zoetis (ZTS) stood at $146.25, denoting a -1.32% move from the preceding trading day.
Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain
ZTS secures CVMP's positive opinion recommending the approval of Portela, a long-acting OA pain therapy for cats, with final decision expected in late 2025.
Should You Invest in the VanEck Agribusiness ETF ( MOO ) ?
Sector ETF report for MOO ...
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR ( SDZNY Quick QuoteSDZNY - ) or Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find ...
Here's Why You Should Add PAHC Stock to Your Portfolio Right Now
Phibro Animal Health posts strong Animal Health sales growth, aided by a Zoetis acquisition, while Mineral Nutrition and Performance Products rebound.
Zoetis ( ZTS ) Stock Sinks As Market Gains: Here's Why
Zoetis (ZTS) reached $149.79 at the closing of the latest trading day, reflecting a -1.29% change compared to its last close.
If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.
Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat - Phibro Animal Health ( NASDAQ:PAHC )
Phibro Animal Health Corporation PAHC shares jumped 17.98% to $37.99 in after-hours trading on Thursday, following strong fourth-quarter results that beat expectations. Check out the current price of PAHC stock here. The global animal health company reported fourth-quarter net sales of $378.7 ...
Phibro Animal Health Q4 Revenue Up 39%
Phibro Animal Health ( NASDAQ:PAHC ) , a veterinary pharmaceutical and nutrition provider, reported earnings for Q4 FY2025 on August 27, 2025, covering the three months ending June 30. Driven by its largest-ever acquisition and strong international appetite for its medicated feed additives, the ...
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
PAHC Stock Up 76.4% in a Year: What's Driving the Rally?
Phibro Animal Health's 76.4% stock surge is fueled by strong sales recovery, global growth and a robust balance sheet.
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Dip into a beaten-down market sector for deals on some proven winners.
If You'd Invested $1,000 in Zoetis ( ZTS ) Stock 10 Years Ago, Here's How Much You'd Have Today
The short-term picture has been less rosy than the longer-term one.
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR ( SDZNY Quick QuoteSDZNY - ) and Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Veterinary Diagnostics Market is expected to generate a revenue of USD 4.52 Billion by 2031, Globally, at 6.59% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Veterinary Diagnostics Market Size is projected to grow at a CAGR of 6.59% from 2024 to 2031, according to a new report published by Verified Market Research®.
2 Stocks to Buy With $5,000 and Hold for a Decade
These two stocks come from completely different industries, but each could boost a long-term investor's returns.
Why Zoetis ( ZTS ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
